• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Christobel E. Selecky, president and CEO, LifeMasters Supported SelfCare


Christobel Selecky has spent 27 years in the healthcare industry, leading LifeMasters since 1996.

Christobel E. Selecky
President and CEO
LifeMasters Supported SelfCare
Irvine, Calif.

Selecky is a strong proponent of transparency in healthcare and as DMAA president, she championed the initiative to develop consensus-based standardized measurements for DM. She considers physician compensation reform, new models of patient engagement and continued work on enhancing the value proposition to be critical to the continued evolution of population health improvement. She also is committed to incorporating DM into care for the fee-for-service Medicare population–a goal she says is a "must"–and integrating DM with wellness and prevention.

Earning a B.S. degree in political science and philosophy from the University of Delaware, she went onto receive a master's degree in public communication from the S.I. Newhouse School of Communications at Syracuse University.

She was also named a 2004 Managed Healthcare Executive Leader in Disease Management.

Related Content
© 2024 MJH Life Sciences

All rights reserved.